cyc 202 has been researched along with Pancreatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kizhake, S; Natarajan, A; Rana, S; Sonawane, YA; Taylor, MA; Zahid, M | 1 |
| Cloyd, JM; Du, S; Mao, Y; Pawlik, TM; Xiao, Y; Xu, G; Zhang, B | 1 |
| Chu, Q; Wang, L; Wang, W; Wang, Y; Zhang, J | 1 |
| Lawrence, TS; Maybaum, J; Morgan, MA; Parsels, JD; Parsels, LA; Tanska, DM | 1 |
| Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J | 1 |
| Barth, P; Göke, R; Lankat-Buttgereit, B; Samans, B; Schmidt, A | 1 |
| Alemany, C; Blasco, F; Calbó, J; Cascalló, M; Ciudad, CJ; Gómez, A; Hernández, JL; Masa, M; Mazo, A; Nicolás, M; Noé, V; Peñuelas, S; Pérez-Torras, S; Piulats, J; Soler, M; Tarrasón, G | 1 |
7 other study(ies) available for cyc 202 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy.
Topics: Amination; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship | 2018 |
Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Topics: Aurora Kinase A; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Lapatinib; Pancreatic Neoplasms; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA; Roscovitine; Serine; Threonine; Trypsin | 2022 |
CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; Dipeptides; Gene Silencing; Humans; Immunoprecipitation; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Receptor, Notch1; RNA, Messenger; Roscovitine; Signal Transduction | 2021 |
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.
Topics: Analysis of Variance; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Deoxycytidine; DNA Replication; Gemcitabine; Histones; Humans; Nucleosides; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Roscovitine; Staining and Labeling | 2018 |
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine | 2011 |
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1).
Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoid Tumor; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Endocrine Gland Neoplasms; Female; Humans; Insulinoma; Lung Neoplasms; Male; Pancreatic Neoplasms; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Purines; Retinoblastoma Protein; RNA-Binding Proteins; Roscovitine | 2004 |
Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Decorin; DNA Primase; DNA-Binding Proteins; Down-Regulation; Extracellular Matrix Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, p16; Genetic Vectors; Histone Deacetylase 1; Histone Deacetylases; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Kinetin; Nuclear Proteins; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proteoglycans; Purines; Reverse Transcriptase Polymerase Chain Reaction; Roscovitine; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein | 2004 |